Lixia Xu
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Topics
- RNA modifications and cancer (23 papers)Cancer-related molecular mechanisms research (18 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Lixia Xu
97 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 1.6k
- Cancer Research 966
- Oncology 622
- Pulmonary and Respiratory Medicine 399
- Immunology 286
Countries citing papers authored by Lixia Xu
This map shows the geographic impact of Lixia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Xu more than expected).
Fields of papers citing papers by Lixia Xu
This network shows the impact of papers produced by Lixia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Xu. The network helps show where Lixia Xu may publish in the future.
Co-authorship network of co-authors of Lixia Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Lixia Xu. A scholar is included among the top collaborators of Lixia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixia Xu. Lixia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 47 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 50 | |
| 8 | 29 | |
| 9 | 84 | |
| 10 | 33 | |
| 11 | 24 | |
| 12 | 20 | |
| 13 | 53 | |
| 14 | 138 | |
| 15 | 98 | |
| 16 | 44 | |
| 17 | 29 | |
| 18 | 6 | |
| 19 | 33 | |
| 20 | 2 |
About Lixia Xu
Lixia Xu is a scholar working on Cancer Research, Hepatology and Oncology, having authored 106 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (23 papers), Cancer-related molecular mechanisms research (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers). The work is most often cited by research in Cancer Research (966 citations), Hepatology (265 citations) and Molecular Biology (1.6k citations). Lixia Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Sui Peng, Xiaoxing Li, Jun Yu, Ming Kuang, Joseph J.�Y. Sung, Junbin Liao, Shuibin Lin, Zihao Dai, Zhenwei Peng and Manling Huang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.